RxDoctor Payments Data

Gloria Galloway, MD

Neurology · Newark, OHNPI 1265433635

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (59.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Livanova USA, Inc. accounts for 84.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $1,007, more than ten times the $68 reported in 2019. That places this record below the midpoint for neurology clinicians in OH, where the typical reported total is $970.

$1,190in general payments, 2019–2025

Across 18 payments — averaging $66.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$1K
  • E.r. Squibb & Sons, L.L.C.$39
  • AbbVie$32
  • Tanabe Pharma America, Inc.$30
  • EMD Serono, Inc.$26
  • Biogen$17
  • plus $40 from 3 others

What the payments were for

  • Travel & lodging$70859%
  • Food & beverage$38933%
  • Education$948%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,190 in reported general payments places this provider in the 50th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio →

Medicare billing

Part B allowed, 2024
$74,149
Medicare patients
316
Services billed
1,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe22$15,801
Nurtec OdtRimegepant Sulfate14$13,583
Memantine Hcl236$9,196
Levetiracetam206$5,552
Rasagiline Mesylate13$2,963
Carbidopa-LevodopaCarbidopa/Levodopa134$2,158
Oxcarbazepine18$2,096
Carbidopa-Levodopa ErCarbidopa/Levodopa26$1,462
Pyridostigmine Bromide17$1,345
Divalproex Sodium ErDivalproex Sodium59$1,182
Topiramate79$1,075
Lamotrigine146$1,064
Zonisamide22$1,017
Donepezil Hcl81$975
Baclofen49$862

Paid to pharmacies, not to this prescriber.

Other neurology in Newark

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →